Specialities
Services
Resource Center
Pricing
About
Contact
Yes, for most procedure-heavy orthopedic groups, the CY 2026 Medicare Physician Fee Schedule quietly reduces orthopedic reimbursement even though the headline conversion factor went up. CMS finalized a 3.26% to 3.77% increase to the conversion factor for 2026, but it paired that increase with a −2.5% “efficiency adjustment” applied to work RVUs on nearly every non-time-based code, and orthopedic surgery is almost entirely non-time-based.
Add a second, less-publicized cut to facility-based practice expense, and many multi-surgeon orthopedic groups are looking at flat or negative net reimbursement in 2026, not the raise the press releases implied. If your billing team is still coding and reporting the same way it did in 2025 — you won’t see this erosion until Q2 collections come in short.
Why This Isn’t the Reimbursement Increase It Looks Like
On October 31, 2025, CMS released the CY 2026 Physician Fee Schedule final rule (CMS-1832-F), setting two conversion factors: $33.5675 for clinicians in a qualifying Advanced Alternative Payment Model, and $33.4009 for everyone else. On paper, that’s good news: a real increase after several years of cuts.
But buried in the same rule is a −2.5% efficiency adjustment applied directly to the work RVUs and intra-service time of nearly all non-time-based codes. CMS says this reflects “efficiency gains” providers have supposedly accumulated over time. Time-based codes, such as E/M visits and behavioral health, are exempt. Orthopedic procedure codes, including joint replacements, arthroscopies, spine procedures, and fracture repairs, are not.
That means the conversion factor bump and the efficiency cut are, for orthopedics, working against each other inside the same rule. Depending on a practice’s specific code mix, the net change to orthopedic reimbursement can land anywhere from a modest gain to an outright reduction, and most groups won’t know which side of that line they’re on until claims start processing under the new rates.
The Second Cut Nobody Is Talking About
CMS also finalized a change to how it allocates indirect practice expense (PE) for services performed in facility settings. Starting in 2026, the portion of indirect PE tied to work RVUs is cut in half for services delivered in a hospital or ambulatory surgery center. CMS’s stated rationale is that facilities, not the physician’s own overhead, now absorb more of that cost.
For high-volume orthopedic procedures performed in ASCs and hospital outpatient departments, this site-of-service adjustment can reduce total RVUs by roughly 10% on top of the efficiency adjustment. A surgeon who does the bulk of joint and spine cases in a facility setting is compounding two separate downward pressures on reimbursement at once, while the practice’s own marketing and referral volume may be climbing.
This is the same pattern we see across every specialty we work with: case volume goes up, the conversion factor headline sounds positive, and margin still shrinks. The mechanism just moved from the payer’s denial desk to the RVU table itself.
What This Looks Like in Real Numbers
Take a mid-size orthopedic group performing 40 total joint replacements a month, split between hospital outpatient and ASC settings. Before 2026, a representative facility-based total knee arthroplasty reimbursed close to $1,410 under the PFS.
Layer in the −2.5% efficiency adjustment and the 50% cut to facility-allocated indirect PE, and that same code can reimburse $60 to $95 less per case once the new RVUs are fully applied, before accounting for any Medicare Advantage plan that mirrors CMS methodology, which most do.
Multiply a $75 per-case reduction across 480 total joints a year, and a single high-volume procedure line alone can bleed $36,000 in annual revenue — without a single claim being denied. Add spine, sports medicine, and hardware-heavy trauma cases into the same RVU logic, and six-figure annual erosion is realistic for a busy multi-surgeon group.
2026 Conversion Factor vs. Efficiency Adjustment: What Actually Reaches Your Bank Account
| Policy Element | What CMS Announced | Net Effect on Reimbursement |
| Conversion Factor (non-APM) | +3.26% ($33.4009) | Positive on its own, but not the full picture |
| Conversion Factor (Advanced APM) | +3.77% ($33.5675) | Positive, applies only to qualifying APM participants |
| Efficiency Adjustment | −2.5% to work RVUs, non-time-based codes | Directly offsets CF gains on nearly all ortho procedure codes |
| Facility-Based Indirect PE Cut | −50% allocation for hospital/ASC services | Additional ~10% RVU reduction on facility-based procedures |
| Combined Impact for High-Volume ASC/Hospital Orthopedics | Multiple adjustments stack | Flat to negative net reimbursement, despite CF headline |
Why Generic Billing Oversight Misses This
Most billing vendors track denials, days in AR, and clean claim rate — all necessary, none of it sufficient here. This isn’t a coding error or a payer rejection; it’s a valuation change baked into the fee schedule itself. A practice can have a 98% clean claim rate and still lose tens of thousands of dollars because nobody re-benchmarked the RVU tables against the specific CPT mix the surgeons actually bill.
This is precisely where specialized orthopedic billing services earn their keep over general-purpose vendors. Catching this requires modeling actual procedure volume against the 2026 RVU files, not waiting for a shortfall to show up in a monthly statement three months later.
It’s also why more multi-surgeon groups are re-evaluating whether their current medical billing and coding services partner has the depth to model fee schedule changes proactively, rather than simply processing claims as they arrive. Generic medical billing services can submit a clean claim; they can’t always tell you why the payment on that clean claim just dropped.
Protecting Orthopedic Reimbursement Under the 2026 Rule
A few things actually move the needle for orthopedic groups right now.
Re-run your top 20 CPT codes by volume against the finalized 2026 RVU files, not the proposed rule numbers, since CMS made adjustments between proposal and final. Separate facility-based from non-facility-based volume, since the indirect PE cut only hits the former.
Flag any code exempt from the efficiency adjustment (time-based and select excluded codes) so you’re not overcorrecting across your entire fee schedule. And build the site-of-service shift into contract renegotiations with commercial and Medicare Advantage payers, since many peg their fee schedules to CMS methodology with a lag.
This is where real revenue cycle management stops being a back-office function and becomes a margin-protection strategy. Groups that treat RCM services as a proactive modeling exercise, not just claims processing, are the ones catching this shift before Q1 2026 collections land short.
Get a Clear Picture of Your 2026 Exposure
Guessing at your exposure under the new RVU tables is expensive. MBC’s orthopedic-focused team can model your actual 2026 reimbursement against your real procedure mix, facility split, and payer contracts — and show you exactly where the efficiency adjustment and site-of-service cut intersect with your highest-volume codes.
If you’re weighing whether your current setup can handle this, our transparent medical billing services pricing is a good place to start the conversation. Call 888-357-3226 or email info@medicalbillersandcoders.com to request a 2026 Orthopedic Reimbursement Impact Review before your next fee schedule update hits.
Summary
The CY 2026 Medicare Physician Fee Schedule raises the conversion factor, but a −2.5% efficiency adjustment on non-time-based codes and a separate 50% cut to facility-allocated indirect practice expense both land squarely on orthopedic procedure coding.
For groups doing significant volume in hospital outpatient or ASC settings, the combined effect can mean flat or shrinking orthopedic reimbursement in 2026, even as the headline numbers suggest a raise. Specialty-specific RCM services that model actual CPT mix against the finalized RVU tables are the difference between catching this early and discovering it in a disappointing Q1 statement.
References:
- Medicare Physician Fee Schedule Final Rule (CMS-1832-F)
- Medicare Physician Fee Schedule Final Rule Summary: CY 2026
FAQs:
It’s a CMS-finalized “efficiency adjustment” that reduces work RVUs by 2.5% on nearly all non-time-based codes, which covers most orthopedic surgical and procedural CPT codes, starting January 1, 2026.
Not fully. The conversion factor rose 3.26% to 3.77%, but the efficiency adjustment applies at the RVU level before the conversion factor is calculated, so the two changes can partially or fully cancel out depending on a practice’s specific code mix.
High-volume facility-based procedures, including total joint replacements, spine fusions, and arthroscopic surgeries performed in hospital outpatient departments or ASCs, face both the efficiency adjustment and the separate indirect practice expense cut.
Many Medicare Advantage and commercial payers benchmark their fee schedules to CMS methodology, often with a lag, so practices should expect similar pressure to eventually appear outside of traditional Medicare as well.
By modeling actual CPT volume against the finalized 2026 RVU files, separating facility from non-facility revenue, and working with orthopedic billing services that track fee schedule changes at the code level rather than only monitoring denials and AR.
With almost 12 years of experience in healthcare revenue cycle management, this Revenue Cycle Specialist brings deep expertise in medical billing, claims optimization, and practice profitability. Shares industry-backed insights focused on improving collections, reducing denials, and driving operational excellence.
